{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2013:RH6WYTMMFQUVZIOTKAWQSRNE3C","short_pith_number":"pith:RH6WYTMM","canonical_record":{"source":{"id":"1307.6275","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2013-07-24T00:41:37Z","cross_cats_sorted":[],"title_canon_sha256":"6cd853c299c40c8255ba1580b0c4ac8f9b85149d01093f69028952afc466f168","abstract_canon_sha256":"80f3747647ea6d0914e8ea47f0005f555f3c75f46ef8e953c418900d14cc6179"},"schema_version":"1.0"},"canonical_sha256":"89fd6c4d8c2c295ca1d3502d0945a4d8ab5bf23cf272eef29efe1ce19ffc2edc","source":{"kind":"arxiv","id":"1307.6275","version":1},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1307.6275","created_at":"2026-05-18T03:17:43Z"},{"alias_kind":"arxiv_version","alias_value":"1307.6275v1","created_at":"2026-05-18T03:17:43Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1307.6275","created_at":"2026-05-18T03:17:43Z"},{"alias_kind":"pith_short_12","alias_value":"RH6WYTMMFQUV","created_at":"2026-05-18T12:27:57Z"},{"alias_kind":"pith_short_16","alias_value":"RH6WYTMMFQUVZIOT","created_at":"2026-05-18T12:27:57Z"},{"alias_kind":"pith_short_8","alias_value":"RH6WYTMM","created_at":"2026-05-18T12:27:57Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2013:RH6WYTMMFQUVZIOTKAWQSRNE3C","target":"record","payload":{"canonical_record":{"source":{"id":"1307.6275","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2013-07-24T00:41:37Z","cross_cats_sorted":[],"title_canon_sha256":"6cd853c299c40c8255ba1580b0c4ac8f9b85149d01093f69028952afc466f168","abstract_canon_sha256":"80f3747647ea6d0914e8ea47f0005f555f3c75f46ef8e953c418900d14cc6179"},"schema_version":"1.0"},"canonical_sha256":"89fd6c4d8c2c295ca1d3502d0945a4d8ab5bf23cf272eef29efe1ce19ffc2edc","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-18T03:17:43.829065Z","signature_b64":"SEMrMITMa+l4C/DPbYTkQNzJFkMQGW2nIs5Ud0NyqhFaI2zy771VMTqVtYrJeCMC68xuMD+kt3tA4lAy4nARCA==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"89fd6c4d8c2c295ca1d3502d0945a4d8ab5bf23cf272eef29efe1ce19ffc2edc","last_reissued_at":"2026-05-18T03:17:43.828635Z","signature_status":"signed_v1","first_computed_at":"2026-05-18T03:17:43.828635Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"1307.6275","source_version":1,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T03:17:43Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"rxVJ40tx17ywXm8NKy7/JZqjEwx0sYVfZpo9DyFJRY8lki4IkenaSQ5vS2+8nbvMqHnJBnRBAMjhXQgV//9FAg==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-07-01T21:52:28.411405Z"},"content_sha256":"da58a96b2980f664fa68e62f3f5e7292067de4e4e33dd59f7d8d322fc87794e9","schema_version":"1.0","event_id":"sha256:da58a96b2980f664fa68e62f3f5e7292067de4e4e33dd59f7d8d322fc87794e9"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2013:RH6WYTMMFQUVZIOTKAWQSRNE3C","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"A Two-Stage, Phase II Clinical Trial Design with Nested Criteria for Early Stopping and Efficacy","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"stat.ME","authors_text":"Daniel Zelterman","submitted_at":"2013-07-24T00:41:37Z","abstract_excerpt":"We propose a two-stage design for a clinical trial with an early stopping rule for safety. We use different criteria to assess early stopping and efficacy. The early stopping rule is based on a criteria that can be determined more quickly than that of efficacy. These separate criteria are also nested in the sense that efficacy is a special case of, but not identical to, the early stopping criteria. The design readily allows for planning in terms of statistical significance, power, and expected sample size necessary to assess an early stopping rule. This method is illustrated with a Phase II de"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1307.6275","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T03:17:43Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"VuOmTXkntKji51A3OLTIx2OtHGwVHvpDP5HEBlVWedhUznKmJhkECfVuxpdGtJlFOuoBh9ro4BVhZiqFZWNxCA==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-07-01T21:52:28.411758Z"},"content_sha256":"5c36ac0e4e278b57183526de5fd08a8ff21686fe2374f4c0efac222ec7f42f00","schema_version":"1.0","event_id":"sha256:5c36ac0e4e278b57183526de5fd08a8ff21686fe2374f4c0efac222ec7f42f00"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/RH6WYTMMFQUVZIOTKAWQSRNE3C/bundle.json","state_url":"https://pith.science/pith/RH6WYTMMFQUVZIOTKAWQSRNE3C/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/RH6WYTMMFQUVZIOTKAWQSRNE3C/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-07-01T21:52:28Z","links":{"resolver":"https://pith.science/pith/RH6WYTMMFQUVZIOTKAWQSRNE3C","bundle":"https://pith.science/pith/RH6WYTMMFQUVZIOTKAWQSRNE3C/bundle.json","state":"https://pith.science/pith/RH6WYTMMFQUVZIOTKAWQSRNE3C/state.json","well_known_bundle":"https://pith.science/.well-known/pith/RH6WYTMMFQUVZIOTKAWQSRNE3C/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2013:RH6WYTMMFQUVZIOTKAWQSRNE3C","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"80f3747647ea6d0914e8ea47f0005f555f3c75f46ef8e953c418900d14cc6179","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2013-07-24T00:41:37Z","title_canon_sha256":"6cd853c299c40c8255ba1580b0c4ac8f9b85149d01093f69028952afc466f168"},"schema_version":"1.0","source":{"id":"1307.6275","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1307.6275","created_at":"2026-05-18T03:17:43Z"},{"alias_kind":"arxiv_version","alias_value":"1307.6275v1","created_at":"2026-05-18T03:17:43Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1307.6275","created_at":"2026-05-18T03:17:43Z"},{"alias_kind":"pith_short_12","alias_value":"RH6WYTMMFQUV","created_at":"2026-05-18T12:27:57Z"},{"alias_kind":"pith_short_16","alias_value":"RH6WYTMMFQUVZIOT","created_at":"2026-05-18T12:27:57Z"},{"alias_kind":"pith_short_8","alias_value":"RH6WYTMM","created_at":"2026-05-18T12:27:57Z"}],"graph_snapshots":[{"event_id":"sha256:5c36ac0e4e278b57183526de5fd08a8ff21686fe2374f4c0efac222ec7f42f00","target":"graph","created_at":"2026-05-18T03:17:43Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"paper":{"abstract_excerpt":"We propose a two-stage design for a clinical trial with an early stopping rule for safety. We use different criteria to assess early stopping and efficacy. The early stopping rule is based on a criteria that can be determined more quickly than that of efficacy. These separate criteria are also nested in the sense that efficacy is a special case of, but not identical to, the early stopping criteria. The design readily allows for planning in terms of statistical significance, power, and expected sample size necessary to assess an early stopping rule. This method is illustrated with a Phase II de","authors_text":"Daniel Zelterman","cross_cats":[],"headline":"","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2013-07-24T00:41:37Z","title":"A Two-Stage, Phase II Clinical Trial Design with Nested Criteria for Early Stopping and Efficacy"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1307.6275","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:da58a96b2980f664fa68e62f3f5e7292067de4e4e33dd59f7d8d322fc87794e9","target":"record","created_at":"2026-05-18T03:17:43Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"80f3747647ea6d0914e8ea47f0005f555f3c75f46ef8e953c418900d14cc6179","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2013-07-24T00:41:37Z","title_canon_sha256":"6cd853c299c40c8255ba1580b0c4ac8f9b85149d01093f69028952afc466f168"},"schema_version":"1.0","source":{"id":"1307.6275","kind":"arxiv","version":1}},"canonical_sha256":"89fd6c4d8c2c295ca1d3502d0945a4d8ab5bf23cf272eef29efe1ce19ffc2edc","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"89fd6c4d8c2c295ca1d3502d0945a4d8ab5bf23cf272eef29efe1ce19ffc2edc","first_computed_at":"2026-05-18T03:17:43.828635Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-05-18T03:17:43.828635Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"SEMrMITMa+l4C/DPbYTkQNzJFkMQGW2nIs5Ud0NyqhFaI2zy771VMTqVtYrJeCMC68xuMD+kt3tA4lAy4nARCA==","signature_status":"signed_v1","signed_at":"2026-05-18T03:17:43.829065Z","signed_message":"canonical_sha256_bytes"},"source_id":"1307.6275","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:da58a96b2980f664fa68e62f3f5e7292067de4e4e33dd59f7d8d322fc87794e9","sha256:5c36ac0e4e278b57183526de5fd08a8ff21686fe2374f4c0efac222ec7f42f00"],"state_sha256":"ffc42d27433b58c8324be929b037d2b36ec5fe9a50de49cc8bb96de41150954e"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"YIxLlrshJlxdRFP39O8ddEWh9jX4wZfDUuFFhjogWIR8sEu9Gc4BXFSA5ZF4VTxnjS+I/AWASgUb+3ahScGPAQ==","signed_message":"bundle_sha256_bytes","signed_at":"2026-07-01T21:52:28.413898Z","bundle_sha256":"fb56f380867a464b9927180e36727f5bba196fa688f873981e9e89abb194103f"}}